April 7, 2022 @ 10:51 pm | Breaking News, Buy Hold Sell, Dividend Income Portfolio, PFE |
Pfizer (PFE) will buy privately held respiratory syncytial virus drug maker ReViral for up to $525 million. Wall Street liked the deal–the stock was up 4.33% today, April 7–because it fits with Pfizer’s RNA virus program–which produced a...
November 16, 2021 @ 7:57 pm | Breaking News, MRK, PFE |
I’m starting up my videos again–this time using YouTube as a platform. My sixty-ninth YouTube video “Trend of the Week Big Pharma for Safety” went up today. Please watch and subscribe to my YouTube channel. And like my video. Here’s the...
December 8, 2020 @ 7:31 pm | Breaking News, PFE |
A 53-page review published as a Food & Drug Administration briefing document today confirms that the vaccine from Pfizer (PFE) and BioNTech (BNTX) meets the agency’s standards for emergency use authorization. The briefing document is the result of two weeks...
December 3, 2020 @ 6:50 pm | Breaking News, Dividend Income Portfolio, PFE |
Pfizer (PFE) stock tumbled Thursday after the company reportedly slashed its expectations for coronavirus vaccine deliveries in 2020 due to supply-chain issues. “Scaling up the raw material supply chain took longer than expected,” a company spokeswoman...
October 16, 2020 @ 6:29 pm | Breaking News, Dividend Income Portfolio, PFE |
In a public letter Pfizer (PFE) CEO Albert Bourla wrote that the company hopes to have initial data from its Phase 3 clinical trail of a coronavirus vaccine by the end of October and that it will wait until the third week in November to file an emergency use...
August 28, 2020 @ 7:29 pm | Breaking News, Dividend Income Portfolio, PFE |
In Special Report: Meeting Your Retirement Challenge on my subscription site JubakAM.com, I suggested that when temporary factors created an opportunity to buy the shares of a solid, predictable, cash flow generating company, with a yield of 4% you should jump at the...
September 11, 2019 @ 7:48 pm | Breaking News, Dividend Income Portfolio, PFE |
Why introduce legislation that will dead on arrival in the Republican controlled Senate? Because House Speaker Nancy Pelosi and other Democrats know that controlling drug prices is extremely popular with voters. And a proposal that is a serious effort to lower drug...
February 26, 2019 @ 7:57 pm | Breaking News, Dividend Income Portfolio, MRK, PFE, Update |
The format was familiar: Seven CEOs sit in front of a Senate Committee probing their industry’s business practices. But whereas a Congressional hearing a decade ago marked a key moment in what was a costly public reckoning for the tobacco industry, today’s...
December 17, 2018 @ 7:34 pm | Buy, Dividend Income Portfolio, PFE |
I’m going to take advantage of the selling in the market in general and in the drug sector in particular–on news of the asbestos liability at Johnson & Johnson and fears of the death of Obamacare (AKA the Affordable Care Act)–to buy Pfizer (PFE) in my Dividend...